Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYOBLOC for Sialorrhea in Parkinson's Disease
NCT00515437Phase 2Completed
- Sponsor
- US WorldMeds
- Start
- Jul 2007
- Primary completion
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type b in sialorrhea, sponsored by US WorldMeds. Started Jul 2007; status: completed.
02
Drugs
botulinum toxin type b
03
Conditions
sialorrhea
Beyond the preview
Go deeper on NCT00515437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00515437.